Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06203_nanopub.RAfzItiuux6zzhg-0CBLTXbUkzDQFemk57JosAaKvjHdg#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB06203 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06203 label "Alogliptin [drugbank:DB06203]" assertion.
- drugbank:DB06203 seeAlso DB06203 assertion.
- drugbank:DB06203 seeAlso alogliptin.html assertion.
- drugbank:DB06203 seeAlso patient-images-side-effects.htm assertion.
- drugbank:DB06203 identifier "drugbank:DB06203" assertion.
- drugbank:DB06203 description "Alogliptin is a selective, orally-bioavailable inhibitor of enzymatic activity of dipeptidyl peptidase-4 (DPP-4). Chemically, alogliptin is prepared as a benzoate salt and exists predominantly as the R-enantiomer (>99%). It undergoes little or no chiral conversion in vivo to the (S)-enantiomer. FDA approved January 25, 2013." assertion.
- drugbank:DB06203 title "Alogliptin" assertion.
- drugbank:DB06203 bio2rdf_vocabulary:identifier "DB06203" assertion.
- drugbank:DB06203 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06203 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06203" assertion.
- drugbank:DB06203 bio2rdf_vocabulary:x-identifiers.org DB06203 assertion.
- drugbank:DB06203 drugbank_vocabulary:drugbank-id "DB06203" assertion.
- drugbank:DB06203 drugbank_vocabulary:x-cas cas:850649-61-5 assertion.
- drugbank:DB06203 drugbank_vocabulary:x-ahfs ahfs:68:20.05 assertion.
- drugbank:DB06203 drugbank_vocabulary:x-atc atc:A10BH04 assertion.
- drugbank:DB06203 drugbank_vocabulary:x-chebi chebi:72323 assertion.
- drugbank:DB06203 drugbank_vocabulary:x-kegg kegg:D06553 assertion.
- drugbank:DB06203 drugbank_vocabulary:x-wikipedia wikipedia:Alogliptin assertion.
- drugbank:DB06203 drugbank_vocabulary:x-ndc ndc:64764-250-30 assertion.